There is considerable evidence that antibiotic inhibitors of protein synthesis, injected intracranially before or just after a learning experience, block memory formation in goldfish 1, chicks 12, and mice 3. However, in none of these studies has the region of inhibition of protein synthesis been localized in anatomical structures. While fluorescein injections into specific mouse cerebral sites have been used to estimate where similarly injected antibiotic inhibitors might act 6 this procedure does not take into account possible differences between the diffusion of antibiotics such as puromycin or cycloheximide and that of the dye. Nor can this procedure measure the duration of action of the drug. In other studies, total incorporated radioactivity has been measured in each of 6 grossly dissected brain regions following brief incorporation of labeled amino acids preceded by intracerebral injection of an antimetabolite 5.
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A simple and more precise estimate of the region of inhibition should be possible by means of radioautography of brain sections following incorporation of labeled amino acids. The present report describes localization of zones of protein synthesis inhibition produced by puromycin or cycloheximide, injected through chronically implanted cannulas into monkey cerebral cortex. The monkey was selected as the experimental animal for the present study because of previous observations that lesions in discrete regions of primate cerebral cortex produce specific and different deficits in learning tasks 9A0. We are engaged in concomitant studies of the behavioral effects of localized inhibition of protein synthesis in the monkey brain.
Three male rhesus monkeys (Macaca mulatta, 4-5 kg) were anesthetized with ketamine hydrochloride (Parke Davis, 25 mg/kg) and chronically implanted under sterile conditions with stainless steel cannulas (23-gauge outer barrel, 27-gauge inner barrel). After exposure of the cranium, a small burr hole was made over the appropriate cortical area, the meninges were penetrated, and the cannula was lowered until the tip was 2-3 mm below the brain surface. The cannula was then secured with screws and dental cement. After a 1-2 week recovery period, antibiotics were injected via the cannulas into anesthetized monkeys. Puromycin dihydrochloride (Nutritional Biochemicals, 17 mg/ml neutralized with NaHCOz in 0.154 M NaC1) or cycloheximide (CXM, Actidione, Upjohn, 1 mg/ml in 0.154 M NaCI) was injected in combination with hyaluronidase (Worthington, 1 mg/ml in 0.154 M NaCI). The enzyme was added to facilitate intracerebral spread of the injected antimetabolite. Unless otherwise specified, 10 pl of hyaluronidase in saline was injected, followed 30 min later by 50 #1 of puromycin or cycloheximide solution, each containing the same concentration of hyaluronidase. For comparison, other sites were injected with 10/~1 of saline followed by CXM without hyaluronidase, or with 10 #1 of hyaluronidase followed by an additional 50/d of hyaluronidase without CXM. The various injections were made at specified times before an injection into the femoral vein of [14C]amino acid dissolved in 3 ml of saline. Following a 35-45 min labeling pulse, an overdose of ketamine was administered, and the animal was perfused with saline followed by 10 ~o formalin. Following perfusion, the brain was blocked in the frontal stereotaxic plane and then removed from the skull. The blocked tissue remained in 10 ~o formalin for 10 days and was then transferred to sucrose-formalin, until it sank. The tissue was next embedded in albumin gel, and 40-60 #m thick sections were cut. Every tenth section was mounted on a 2.5 in. × 3 in. glass slide and dried. The dried sections were placed in contact with Kodak No-screen X-ray film, which was exposed in a light-tight box for 6-7 weeks at room temperature and then discarded or stored for possible re-exposure. Films were developed with Kodak X-ray developer and fixer. Brain sections adjacent to those used for radioautography were mounted, stained with thionin, and examined for possible changes in histomorphology. Localized cortical zones of protein inhibition can clearly be visualized in the radioautograms (Fig. 1B and C) . In each instance, the antibiotic-hyaluronidase solution was injected I h before the labeled amino acid injection. The diameter of the zone of inhibition produced by either antimetabolite with hyaluronidase was found to be 4-9 mm in the maximal extent. In general, inhibition is more easily seen in the gray matter, where basal labeling is heaviest, but inhibition in the white matter is also apparent (see Fig. 1B) . Hyaluronidase itself appears to have no effect on protein labeling. Comparison of maximal diameter of zones of inhibition produced by CXM + hyaluronidase with those produced by CXM alone suggests that hyaluronidase does however enlarge the zone of protein synthesis inhibition (Fig. 1D) , although the extent of the effect has not been established.
The time course of inhibition was examined by injecting antimetabolites at various times before the terminal labeling period (Fig. 1D-F ). An injection of 50 #g of CXM or of 850 #g of puromycin, each in 50 #1, produced a marked zone of inhibition 1 h after injection. Inhibition following CXM injection was greatly diminished by 5 h. In contrast, puromycin produced a marked degree of inhibition still present at 5 h; after 24 h there was no remaining evidence of inhibition. A similar difference in the time course of protein synthesis block by cycloheximide and puromycin has been reported in goldfish 11 and mouse 2 brains.
Examination of thionin-stained sections taken from tissue in the region of each injection site revealed minimal vascular and phagocytic reaction attributable to cannula implantation. Some acute traumatic reaction, evidenced by proliferation of polymorphonuclear leucocytes, was observed at all injection sites. This reaction could therefore not be attributed to the antibiotics themselves. In other histological studies, Gambetti et ak 7, using light microscopy, found no lesions produced in mouse entorhinal cortex by injection of puromycin 7-36 h before death. However, at the ultrastructural level, mitochondrial swelling and disaggregation of polyribosomes were observed 7-27 h after puromycin injection, but not after injections of acetoxycycloheximide s, a powerful protein synthesis inhibitor similar in structure and mechanism of action to CXM (see ref. 4 ). Behaviorally, we find no evidence of lasting effects of multiple injections of CXM bilaterally into inferotemporal cortex of a monkey. Four months after 8 injections, there was no obvious deterioration of performance in a visual discrimination task, as might be expected following surgical lesions of this cortical region 10.
The present findings suggest that localized, reversible blocking of protein synthesis, produced by drugs injected through chronically implanted cannulas, may prove useful in the analysis and localization of higher brain functions, including those previously localized by surgical ablations.
